His laboratory uses the combination of genetics, molecular biology, and informatics to investigate pathways underlying common cardiovascular and metabolic disorders. They exploit natural genetic variation among inbred strains of mice (and among human populations when possible) to identify novel targets and formulate hypotheses, and perform validation using experimental perturbations in mice. A major focus has been the interactions of lipid metabolism and inflammation in cardiovascular disease and metabolic syndrome.